Literature DB >> 28315077

Setting the stage for the next step in cardiac amyloidosis imaging: Serial quantitative studies to assess disease activity.

Prem Soman1, Ahmad Masri2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28315077     DOI： 10.1007/s12350-017-0846-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  22 in total

1.  Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.

Authors:  Adam Castaño; Sabahat Bokhari; Mathew S Maurer
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

2.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

Authors:  Dominique Delbeke; R Edward Coleman; Milton J Guiberteau; Manuel L Brown; Henry D Royal; Barry A Siegel; David W Townsend; Lincoln L Berland; J Anthony Parker; Karl Hubner; Michael G Stabin; George Zubal; Marc Kachelriess; Valerie Cronin; Scott Holbrook
Journal:  J Nucl Med       Date:  2006-05       Impact factor: 10.057

3.  Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis.

Authors:  M A Gertz; M L Brown; M F Hauser; R A Kyle
Journal:  Arch Intern Med       Date:  1987-06

4.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

5.  11C-Pittsburgh B PET imaging in cardiac amyloidosis.

Authors:  Seung-Pyo Lee; Eun Seong Lee; Hongyoon Choi; Hyung-Jun Im; Youngil Koh; Min-Ho Lee; Ji-Hyun Kwon; Jin Chul Paeng; Hyung-Kwan Kim; Gi Jeong Cheon; Yong-Jin Kim; Inho Kim; Sung-Soo Yoon; Jeong-Wook Seo; Dae-Won Sohn
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-04

6.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

7.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

Review 8.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

Review 9.  Ubiquitous amyloids.

Authors:  Wojciech Pulawski; Umesh Ghoshdastider; Vincenza Andrisano; Slawomir Filipek
Journal:  Appl Biochem Biotechnol       Date:  2012-02-19       Impact factor: 2.926

10.  Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.

Authors:  Marianna Fontana; Silvia Pica; Patricia Reant; Amna Abdel-Gadir; Thomas A Treibel; Sanjay M Banypersad; Viviana Maestrini; William Barcella; Stefania Rosmini; Heerajnarain Bulluck; Rabya H Sayed; Ketna Patel; Shameem Mamhood; Chiara Bucciarelli-Ducci; Carol J Whelan; Anna S Herrey; Helen J Lachmann; Ashutosh D Wechalekar; Charlotte H Manisty; Eric B Schelbert; Peter Kellman; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  Circulation       Date:  2015-09-11       Impact factor: 29.690
View more
  1 in total

1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.